The Air Force is pressing to find out why some Airmen and former Airmen who worked wth the nation's intercontinental continental ballistic missile fleet are being diagnosed with blood cancer—years after the service dismissed such concerns in the early 2000s.
The Air Force’s study of possible links to elevated rates of cancer among personnel who worked on intercontinental continental ballistic missiles has begun, the commander in charge of the U.S. ICBM fleet confirmed March 28. The initial phase of that study will mine cancer registries ...
Air Force Global Strike Command is launching a new study of cancer risks among Airmen and Guardians who worked near intercontinental ballistic missiles and is developing new resources for current and former service members and their families.